These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 18028377)

  • 41. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
    White WM; Pickens RB; Doggweiler R; Klein FA
    J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland.
    Montoya FJ; Riddell CE; Caesar R; Hague S
    Eye (Lond); 2002 Nov; 16(6):705-9. PubMed ID: 12439663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin type A in prophylactic treatment of migraine.
    Anand KS; Prasad A; Singh MM; Sharma S; Bala K
    Am J Ther; 2006; 13(3):183-7. PubMed ID: 16772757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of tension-type headache with botulinum toxin: a pilot study.
    Schulte-Mattler WJ; Wieser T; Zierz S
    Eur J Med Res; 1999 May; 4(5):183-6. PubMed ID: 10336407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids.
    de Boulle K
    J Cosmet Laser Ther; 2008 Jun; 10(2):87-92. PubMed ID: 18569261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
    Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K
    Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
    Brin MF; Comella CL; Jankovic J; Lai F; Naumann M;
    Mov Disord; 2008 Jul; 23(10):1353-60. PubMed ID: 18546321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prophylactic treatment of chronic daily headache.
    Mathew NT
    Headache; 2006; 46(10):1552-64. PubMed ID: 17115988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nummular headache.
    Grosberg BM; Solomon S; Lipton RB
    Curr Pain Headache Rep; 2007 Aug; 11(4):310-2. PubMed ID: 17686396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nummular headache: a series with symptomatic and primary cases.
    Alvaro LC; García JM; Areitio E
    Cephalalgia; 2009 Mar; 29(3):379-83. PubMed ID: 19220316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prophylaxis of chronic daily headache with a simplified regimen of subcutaneous administration of botulinum toxin type A].
    Martín-Araguz A; Garrido-Carrión A; Fernández-Armayor V
    Rev Neurol; 2007 Oct 1-15; 45(7):385-8. PubMed ID: 17918102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
    Chajchir I; Modi P; Chajchir A
    Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis.
    Trindade de Almeida AR; Marques E; de Almeida J; Cunha T; Boraso R
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S37-43. PubMed ID: 17241413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bifocal nummular headache: a series of 6 new cases.
    Guerrero AL; Cuadrado ML; García-García ME; Cortijo E; Herrero-Velázquez S; Rodríguez O; Mulero P; Porta-Etessam J
    Headache; 2011; 51(7):1161-6. PubMed ID: 21675970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series.
    Kapural L; Stillman M; Kapural M; McIntyre P; Guirgius M; Mekhail N
    Pain Pract; 2007 Dec; 7(4):337-40. PubMed ID: 17986166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.